Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi

International Journal of Cancer. Journal International Du Cancer
Xinmin ZhengDavid Shalloway

Abstract

We show that siRNA-mediated suppression of protein tyrosine phosphatase alpha (PTP alpha) reduces Src activity 2 to 4-fold in breast, colon and other human cancer cell lines. Src and PTP alpha RNAi induced apoptosis in estrogen receptor (ER)-negative breast cancer and colon cancer cells, but not in immortalized noncancerous breast cells, ER-positive breast cancer cells or other cancer cell types tested. RNAi of other Src family members (Fyn and Yes) or of PTP1B, a phosphatase previously suggested to be an activator of Src in breast cancer, had no effect. Although further tests with primary tumor tissues are required, the unexpected correlation between ER status and Src/PTP alpha dependence in breast cancer cell lines may be important for planning therapeutic strategies, and the insensitivity of normal breast cells to the RNAi highlights the potential of PTP alpha, which may be easier to target than Src, as a therapeutic target in ER-negative breast cancer.

References

May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J BartekJ Taylor-Papadimitriou
Feb 1, 1985·Metabolism: Clinical and Experimental·W M BurchR E Wuthier
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·D K LuttrellT M Gilmer
Jan 1, 1994·Molecular and Cellular Biology·S K MuthuswamyW J Muller
Mar 4, 2000·The EMBO Journal·X M ZhengD Shalloway
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·A deFazioR L Sutherland
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Jul 11, 2001·The Journal of Biological Chemistry·C BougeretH Avraham
Nov 2, 2001·The EMBO Journal·X M Zheng, D Shalloway
Apr 20, 2002·Current Opinion in Infectious Diseases·Mark Wright, Janice Main
Nov 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Chi-Wai WongBoris J Cheskis
Nov 7, 2002·Oncogene·T Christopher WindhamGary E Gallick
Jan 22, 2003·The Biochemical Journal·Jenny BainPhilip Cohen
Apr 16, 2003·The Journal of Cell Biology·Gotz von WichertMichael P Sheetz
Jun 2, 2004·Nature Reviews. Cancer·Timothy J Yeatman
Sep 24, 2004·Cancer Cell·Rumey Ishizawar, Sarah J Parsons
Oct 19, 2004·Oncogene·Martin P Playford, Michael D Schaller
Oct 27, 2004·Biochemical and Biophysical Research Communications·Robert Roskoski
Sep 15, 2005·The FEBS Journal·Alexander Bürkle
May 27, 2006·The Journal of Biological Chemistry·Lorena GonzálezJorge Martín-Pérez

❮ Previous
Next ❯

Citations

Jun 13, 2013·Biochimica Et Biophysica Acta·Caroline E Nunes-XavierRafael Pulido
May 19, 2012·ACS Chemical Biology·Kristoffer R BrandvoldMatthew B Soellner
Aug 30, 2012·ACS Chemical Biology·Frank E KwarcinskiMatthew B Soellner
Jun 17, 2010·Annals of Surgical Oncology·Norikatsu MiyoshiMasaki Mori
Sep 6, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sami Ben HamidaDorit Ron
Mar 19, 2013·Oncogene·J StebbingG Giamas
May 16, 2008·Expert Opinion on Therapeutic Targets·Stephen Hiscox, Robert I Nicholson
Apr 24, 2012·Biochimica Et Biophysica Acta·Elmer HoekstraGwenny M Fuhler
Jan 31, 2013·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Michelle LeonardA Sue Menko
Jan 25, 2011·Journal of Neurochemistry·Fèlix JunyentAntoni Camins
Jun 5, 2013·International Journal of Cancer. Journal International Du Cancer·Antonios N GargalionisAthanasios G Papavassiliou
Jun 16, 2010·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Barbara Tremper-WellsDavid Shalloway
May 6, 2015·The FEBS Journal·Xueping LaiJian Huang
Mar 28, 2013·Acta Biochimica Et Biophysica Sinica·Jiamin WangXinmin Zheng
Nov 12, 2009·British Journal of Cancer·N MiyoshiM Mori
Jun 3, 2020·Bioscience Reports·Zhenlin WangMeiqing Lou
May 20, 2015·Oncotarget·María Pilar Sánchez-BailónJorge Martín-Pérez
Apr 15, 2019·Cellular and Molecular Life Sciences : CMLS·Mariana Tannús RuckertVanessa Silva Silveira
Jan 2, 2021·Critical Reviews in Oncology/hematology·Shokooh SalimimoghadamBehzad Baradaran
Mar 21, 2015·ACS Chemical Biology·Kristoffer R BrandvoldMatthew B Soellner
Sep 10, 2013·ACS Medicinal Chemistry Letters·Kristin S KoMatthew B Soellner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis